CONMED provides preliminary 2026 guidance at J.P. Morgan Healthcare Conference; no figures in filing

CONMED Corp

Presented at J.P. Morgan 44th Annual Healthcare Conference on January 12, 2026.
Preliminary 2026 financial guidance was included in the investor presentation.
No specific revenue, EPS, or other guidance figures were disclosed in the filing text.
Presentation available on CONMED's website under Investors > Presentations.
CFO Todd W. Garner and CEO Pat J. Beyer presented.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.